Skip to content
Homepage
Author:
Zomedica Corp.
Posted Date:
July 15, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on July 24, 2026: Zomedica’s Sales Organization – From Strategy to the Clinic
Zomedica Corp.
July 15, 2026
Zomedica’s Assisi Loop(R) Products Designated “Fear Free(R)” as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC
Zomedica Corp.
June 25, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on June 26, 2026: The Five Pillars of Zomedica – Framework for Clinical Value and Shareholder Returns
Zomedica Corp.
June 10, 2026
Zomedica’s PulseVet System Repeats as Official Shock Wave of the United States Eventing Association
Zomedica Corp.
May 20, 2026
Zomedica Announces “Fifth Friday at Four” Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market
Zomedica Corp.
May 14, 2026
Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Zomedica Corp.
May 8, 2026
Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Zomedica Corp.
April 16, 2026
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
Zomedica Corp.
March 18, 2026
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Zomedica Corp.
March 16, 2026
Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th “Fourth Friday at Four” Investor Webinar
Zomedica Corp.
March 10, 2026
1
2
Next
